Cone Procedure to Treat Ebstein's Anomaly - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Cone Procedure to Treat Ebstein's Anomaly

  • By

  • na

  • November 22, 2023

  • 4 min

Share

Clinical Scorecard: Cone Procedure to Treat Ebstein's Anomaly

At a Glance

CategoryDetail
ConditionEbstein's Anomaly
Key MechanismsDisplacement of the tricuspid valve leading to regurgitation and potential heart failure.
Target PopulationChildren and adults with Ebstein's anomaly.
Care SettingPediatric and adult congenital heart disease programs.

Key Highlights

  • Cone reconstruction is a promising alternative to tricuspid valve replacement.
  • The procedure allows the valve to grow with the child, reducing the need for future interventions.
  • Cone reconstruction has shown higher success rates and lower incidence of tricuspid regurgitation compared to traditional valve replacement.

Guideline-Based Recommendations

Diagnosis

  • Assess anatomical and physiological presentations of Ebstein's anomaly.

Management

  • Consider cone reconstruction for eligible patients over traditional valve replacement.

Monitoring & Follow-up

  • Lifelong cardiovascular monitoring and therapy are essential for managing complications.

Risks

  • Potential for arrhythmias, cyanosis, and heart failure without treatment.

Patient & Prescribing Data

Patients with Ebstein's anomaly, from neonates to adults.

Cone reconstruction is a safe and effective treatment option with long-term durability.

Clinical Best Practices

  • Perform cone reconstruction only by specialized cardiothoracic surgeons.
  • Provide comprehensive care through a dedicated congenital heart disease program.

Related Resources & Content

Original Source(s)

Related Content